Observational usage study of Faslodex in patients suffering from initial breast cancer in France
Study identifier:NIS-OFR-FAS-2007/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Observational usage study of Faslodex in patients suffering from initial breast cancer in France
Medical condition
Breast Cancer
Phase
-
Healthy volunteers
No
Study drug
-
Sex
Female
Actual Enrollment
217
Study type
Observational
Age
N/A
Date
Study Start Date: 01 May 2007
Primary Completion Date: -
Study Completion Date: 01 Jun 2007
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 Patients suffering from initial breast cancer, treated with Faslodex, treatment which was stopped during 2007 | - |
Contacts
Investigators
Principal Investigator
Alain FLINOIS
TNS Healthcare - France138, avenue Marx Dormoy92120 Montrouge
